Evidence map›Paper›PMID 38054715›Full record

ArticleMicrobiology spectrum2024

Toxin/antitoxin systems induce persistence and work in concert with restriction/modification systems to inhibit phage.

Laura Fernández-García, Sooyeon Song, Joy Kirigo, Michael E Battisti, Maiken E Petersen, María Tomás, Thomas K Wood

Abstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Prokaryotic homeostasis - a solution to thrive and survive.Frontiers in molecular biosciences · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Phages produce persisters.Microbial biotechnology · 2024
    Article
  12. Article
  13. Correlation ofInternational journal of molecular sciences · 2024
    Article
  14. Review
  15. Review
  16. Review
  17. Ribosome inactivation byFrontiers in microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laura Fernández-GarcíaDepartment of Chemical Engineering, Pennsylvania State University , University Park, Pennsylvania, USA.
Sooyeon SongDepartment of Chemical Engineering, Pennsylvania State University , University Park, Pennsylvania, USA.
Joy KirigoDepartment of Chemical Engineering, Pennsylvania State University , University Park, Pennsylvania, USA.
Michael E BattistiDepartment of Chemical Engineering, Pennsylvania State University , University Park, Pennsylvania, USA.
Maiken E PetersenDepartment of Chemical Engineering, Pennsylvania State University , University Park, Pennsylvania, USA.
María TomásMicrobiology Department of Hospital A Coruña (CHUAC), Microbiology Translational and Multidisciplinary (MicroTM)-Research Institute Biomedical A Coruña (INIBIC) and University of A Coruña (UDC) , A Coruña, Spain.
Thomas K WoodDepartment of Chemical Engineering, Pennsylvania State University , University Park, Pennsylvania, USA.ORCID 0000-0002-6258-529X

Funding

Fulbright Scholar FellowshipNational Plan for Scientific ResearchNational Research Foundation of Korea (NRF) NRF-2020R1F1A1072397Xunta de Galicia Postdoctoral Grant
6 · The paper itself

Abstract

importanceTo date, there are no reports of phage infection-inducing persistence. Therefore, our results are important since we show for the first time that a phage-defense system, the MqsRAC toxin/antitoxin system, allows the host to survive infection by forming persister cells, rather than inducing cell suicide. Moreover, we demonstrate that the MqsRAC system works in concert with restriction/modification systems. These results imply that if phage therapy is to be successful, anti-persister compounds need to be administered along with phages.

Indexed as

AntitoxinsBacteriophagesDNA Restriction-Modification EnzymesHumansAntitoxinsDNA Restriction-Modification Enzymespersistencephage inhibitiontoxin/antitoxin systems

Identifiers

PMID38054715
PMCPMC10783111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.